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Objectives: To investigate requests for common
prescription-only aphrodisiacs across community phar-
macies in the Alahsa region of KSA.
Methods: A cross-sectional study was conducted among
conveniently selected pharmacies in the eastern region of
Alahsa, KSA. Self-administered questionnaires were
directly distributed to 73 consenting community phar-
macies. Completed questionnaires were coded, reviewed
for accuracy and entered into a database in Statistical
Package for the Social Sciences (Version 19.0; IBM
Corporation, Somers, NY). The data were analysed using
descriptive analysis.
Results: The survey response rate was 72.60%. With
respect to the availability of aphrodisiacs and sexual
supplements, most of the pharmacists disclosed that they
had stocks of Viagra and Cialis. The most common men’s
health complication reported by pharmacists was erectile
dysfunction (n ¼ 12, 22.6%), followed by premature
ejaculation (n ¼ 4, 7.5%) and low sexual desire (n ¼ 1,
1.9%). Less than half of pharmacists (n ¼ 9, 16.9%) cited
Viagra and Cialis as preferred drugs for treating prema-
ture ejaculation. Approximately 32 (60.3%) proposed
delayed sprays as the first line of action, while 13 (24.5%)
considered antidepressants as their first-choice drug.
Conclusion: The non-prescription dispensing of
prescription-only medicines, including sexual enhance-
ment products, is common in KSA. The majority of
pharmacists continue to violate pharmaceutical lawsy. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.05.002
A.K. Suleiman et al.414without recognizing the potential harm they are causing
their communities. Stakeholders should organize training
and certification initiatives to ensure that pharmacists are
aware of and comply with national pharmaceutical laws.
These agencies should also ensure that pharmacies
maintain safe and ethical practices.
Keywords: Aphoristic; Community pharmacy; KSA; Prescription-
only medicines; Viagra
 2016 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
The over-the-counter or consumer-directed sale of
aphrodisiac medicine is an emerging problem in KSA.
Scientifically proven aphrodisiacs should only be prescribed
and dispensed by legal, authorized medical personnel.1
Currently, however, the non-prescription request and
patient-directed use of medicines remains a major challenge,
as non-prescription sale is a frequent practice in pharmacies
in KSA.2 Most community pharmacies may primarily be
driven by profits, meaning that the desire to meet monthly
sales targets compels the pharmacist to dispense medicine
without a prescription.3e5
Men’s health issues, including the problem of premature
ejaculation (PE), are a major issue affecting 30e40% of
sexually active men.6 In a study conducted in KSA,7 the
prevalence of PE was found to be 32.4% among patients
below 50 years of age, compared to 67.6% among patients
over 50 years of age. The incidence of PE was found to be
significant among patients with cardiovascular disease and
diabetes mellitus.7 Interestingly, various observational
studies have reported the beneficial effects of selective
serotonin reuptake inhibitors (SSRIs) among patients with
PE.8,9 In addition to PE, erectile dysfunction (ED) is
another main challenge to men’s sexual health and is
considered a major cause of poor relations and sexual
satisfaction among young and middle-aged men.8
Phosphodiesterase 5 (PDE5) inhibitors are currently the
first choice treatment for erectile dysfunction (ED) among
a wide variety of patients.10 Given the presence of social
marketing programs and the affordable price of PDE5-
inhibitor drugs such as sildenafil, erectile dysfunction has
remained in the public eye.11 Researchers12 found that Saudi
men frequently submitted requests for oral anti-erectile
dysfunction drugs (AEDD) without a prescription.12
While13 reported prevalence of ED of greater than 40.0%
among Arab men. Common risk factors associated with
ED include diabetes mellitus, hypertension, smoking,
alcohol consumption and drug addiction.14
However, little is currently known about non-prescription
requests for aphrodisiacs in KSA. Not enough data are
available to meaningfully discuss the situation in rural areas
of the eastern province (Alahsa) of KSA. Previous studies of
Alahsa have reported the frequent non-prescription sale ofantibiotics.4e6 However, it is not known how severe this
situation is in regards to aphrodisiacs. Many questions
need to be answered, such as the following: Which age
groups visit pharmacies frequently? What products do they
request, and how do pharmacists respond? This study was
conducted to address this gap by investigating requests for
common non-prescribed aphrodisiacs in community phar-
macies in Alahsa, KSA.Materials and Methods
A cross-sectional study was performed among conve-
niently selected pharmacies in the eastern region of Alahsa,
KSA. A self-administered questionnaire was developed to
meet the objectives of the study. Data collection took place
from 1 July 2014 through 31 September 2014.Study design
In this cross-sectional study, self-administered question-
naires were disseminated directly to 73 consenting commu-
nity pharmacies in Alahsa, KSA. The researchers distributed
the questionnaires to the community pharmacies with an
explanatory cover letter and prepaid return envelope. After
explaining the objective of the study, the researchers
requested that the pharmacists complete a consent form to
participate in this study.The instrument
The questionnaire comprises three sections. The first
section consists of five questions about respondents’ de-
mographics, including nationality, age, qualification level,
experience and pharmacy type. Section two focuses on the
availability of medicines that improve or enhance sexual
performance. This section consists of five questions that
include the types of sexual drugs/products available, the
frequency of patients’ requests, common complications, the
age groups of those making these requests and the avail-
ability of female sexual drugs/products. The third section of
the questionnaire contains four questions focussing on the
frequency of male customers complaining of common sexual
problems, the frequency of complaints about premature
ejaculation, the frequency of complaints about premature
ejaculation in different age groups and pharmacists’ first-,
second- and third-choice recommendations for sexual drugs/
products. The reliability of the tool was assessed using
Cronbach’s alpha, and the tool was found to be reliable with
an alpha value of 0.70.Data analysis and ethical approval
Completed questionnaires were coded, reviewed for ac-
curacy, entered into a database in Statistical Package for the
Social Sciences (Version 19.0; IBM Corporation, Somers,
NY) and analysed using descriptive analysis. Descriptive
statistics were applied and results were presented as numbers
and percentages. The study protocol was approved by the
dean of scientific research of King Faisal University.
Table 2: Aphrodisiacs available at pharmacies.
Drug name Availability N (%)
Viagra 53 (100%)
Cialis 53 (100%)
Levitra 26 (49.1%)
Ginseng 52 (98.1%)
High-potency zinc formula 38 (71.7%),
Vitamins and minerals 49 (94.2)
Yohimbine 39 (73.6)
Arginine 35 (66%),
Delay sprays 37 (69.8%)
Local anaesthetics 49 (92.5%)
Chinese medicines 2 (3.8%)
Stamina 1 (1.9%)
Aphrodisiac products without prescriptions 415Results
Fifty-three community pharmacists participated in this
study, with a response rate of 72.60%. Most of the phar-
macists who participated in this study were Egyptians (42, or
79.2%), followed by Indians (5, or 9.4%). A majority of the
pharmacists (25, or 47.1%) were from the age group 26e30
years and primarily had 4e10 years of professional experi-
ence (29, or 54.7%). Details are shown in Table 1.
With respect to the availability of aphrodisiacs and sexual
supplements, most of the pharmacists disclosed that they had
stocks of Viagra and Cialis. Surprisingly, the community
pharmacies also had stocks of some herbal preparations
containing ginseng and yohimbine. Details about the
aphrodisiac product inventory are shown in Table 2.
The most common men’s health complications reported
by the pharmacists included ED (n ¼ 12, 22.6%), followed
by PE (n ¼ 4, 7.5%) and low sexual desire (n ¼ 1, 1.9%).
Eighteen pharmacists (34%) reported ED and PE as com-
mon problems. However, six pharmacists (11.3%) listed
impotence and low sexual desire as frequent complaints. Less
than a quarter of the pharmacists (n¼ 12, 22.7%) considered
all aforementioned complications as common complaints.
The use of sexual medicines varied according to the different
age groups. The most frequent customers (n ¼ 43, 81.1%)
were aged 41e45 years and older. Among them, community
pharmacists reported PE as a common complaint. Premature
ejaculation was observed more frequently in the age group
26e35 years (n¼ 17, 32%) and 36e45 years (n¼ 11, 20.7%).
Less than half of the pharmacists (n ¼ 9, 34.6%) listed
Viagra/Cialis as a top-choice drug to treat premature ejac-
ulation. Approximately 32 (78%) suggested delayed sprays
as first line of action while 13 (39.4%) considered antide-
pressants as the best option to treat premature ejaculation. In
addition, nine (42.9%) pharmacists suggested ginseng as a
second choice. Most of the pharmacists (13, or 76.5%)Table 1: Participant demographics.
Demographics N (%)
Nationality Saudi 1 (1.9%)
Egyptian 42 (79.2%)
Jordanian 1 (1.9)
Indian 5 (9.4%)
Other 4 (7.5%)
Age 20e25 years 5 (9.4%)
26e30 years 25 (47.2%)
31e35 years 13 (24.5%)
36e40 years 5 (9.4%)
41e45 years 1 (1.9%)
46e50 years 3 (5.7%)
More than 50 years 1 (1.9%)
Educational
qualification
Bachelor of pharmacy (B
Pharm)
46 (86.8%)
Doctorate of pharmacy
(Pharm D)
5 (9.4%)
Master 2 (3.8%)
Professional
experience
1e3 years 10 (18.9%)
4e10 years 29 (54.7%)
More than 10 years 14 (26.4%)
Type of pharmacy Independent pharmacy 9 (17%)
Chain pharmacy 44 (83%)considered a high-potency zinc formula to be the third-best
option. Details are provided in Table 3.Discussion
All of the pharmacists in the study sample were male
because only male pharmacists are allowed to work in
community pharmacies in KSA.15 Furthermore, there was
only one Saudi pharmacist in the study, as most of the
150e200 pharmacists who graduate from local
pharmaceutical colleges each year join the public sector
because of better salaries and opportunities for promotion
as stated by Suleiman.15
The role of community pharmacists is expanding with the
advancement of health care services.16 Similarly, community
pharmacists’ specialized role in providing sexual health
services has become vital for both male and female
patients. To meet these modern requirements, health
authorities are keen to make greater use of community
pharmacies to promote sexual health.17 Hence, pharmacists
who are competent and comfortable discussing sexual
function and dysfunction with patients can positivelyTable 3: Sale frequency of commonly available sexual
enhancement products.
Drug name Sale frequency
Daily After 2e3
days
Weekly Monthly
Viagra 12 (22.6%) 6 (11.3%) 35 (66%)
Cialis 14 (26.4%) 7 (13.3%) 32 (60.4%)
Levitra 14 (36.8%) 11 (28.9%) 26 (49.1%)
Ginseng 5 (11.6%) 10 (23.3%) 12 (27.9%) 16 (37.2%)
High-potency
zinc formula
8 (15.1%) 9 (20.9%) 9 (20.9%) 17 (32.1%)
Vitamins and
minerals
6 (13%) 9 (19.6%) 11 (20.8) 20 (43.5%)
Yohimbine 2 (5.6%) 2 (5.6%) 11 (30.6%) 21 (58.3%)
Arginine 3 (8.8%) 1 (2.9%) 3 (8.8%) 27 (79.4%)
Delay sprays 5 (12.8%) 10 (25.6%) 10 (25.6%) 19 (35.9%)
Local
anaesthetics
7 (15%) 12 (26.1%) 13 (28.3%) 14 (30.6%)
Massage oils 3 (8.6%) 4 (11.4%) 13 (37.1%) 15 (42.9%)
Stamina 1 (9.1%) 2 (18.2%) 3 (27.3%) 5 (45.5%)
A.K. Suleiman et al.416contribute to these patients’ therapeutic outcomes as well as
their quality of life.18
Indicative of the need for professional advancement,
pharmacists who enrolled in this study lacked the necessary
knowledge to address issues related to the possible compli-
cations of using of sexual-enhancing products and alterna-
tive remedies. In this study of Alahsa, it was observed that
pharmacists usually ask neither for prescriptions from the
patients nor about patients’ other medical conditions.6 If a
patient has other medical conditions, sexual enhancement
products should be used with caution because of potential
adverse effects and interactions. In a multicentre cross-
sectional study carried out in KSA, 388 patients who had
attended 6 andrology and urology clinics within a period of 3
months were enrolled to determine risk factors for ED. The
results revealed that 30% of them were diabetic, 15% were
hypertensive, and 56% were smokers.19 In another study
conducted in KSA, 186 diabetic patients showed
cardiovascular risk factors including hypertension (34.9%),
smoking (13.4%), obesity (40%) and dyslipidaemia
(16.6%).14,20 These findings suggest that, in KSA, ED is
accompanied by other medical conditions. Thus, when
providing any treatment for ED, these comorbidities
should be taken into consideration to avoid complications.
In light of these findings, it is imperative that pharmacists
ask patients about their conditions and provide them with
appropriate advice that may increase their awareness of
their condition and prevent them from developing other
serious health problems.
Recently, concerns regarding the use of citalopram have
been raised, as it is associated with potential adverse cardiac
effects such as QT prolongation on the electrocardiograph
(ECG). In August 2011, the Food and Drug Administration
(FDA) issued a safety bulletin advising healthcare pro-
fessionals and patients to avoid using citalopram on a long-
term basis, particularly in doses greater than 40 mg daily or
greater than 20 mg daily in patients over 60 years of age or
with established hepatic impairment.21 The chances of
cardiotoxicity become significant with biochemical
disturbances, pre-existing cardiac disease, concomitant
drug use and long QT syndrome.22 In terms of side effects,
sexual dysfunctions such as sexual desire and arousal
difficulties, delayed ejaculation, absent or delayed orgasm
and even ED are the main side effects of SSRIs.23 In
addition, sildenafil drugs usually cause a mild lowering of
blood pressure and have a potential risk for patients taking
any form of nitrate medication. Furthermore, it was
shown24 that the use of sildenafil is associated with
increased mortality and morbidity. Even when the many
adverse events of sexual enhancement products are known,
the majority of community pharmacies in Alahsa continue
to engage in the non-prescription sale of sexual products.
Pharmacists are in a critical position within the health care
system, though educating them about the benefits and risks
of sexual enhancement products, as well as changing their
attitudes towards their role as health care providers, can be
challenging. With access to additional training and educa-
tional programs, pharmacists may be better equipped to in-
crease the health literacy of patients regarding the use of
sexual enhancement products.
Recently, self-medication with sexual drugs has become
very common. As Marmor and Kessler reported,24 the illicitand off-label use of sildenafil solely to intensify and prolong
the erectile response has led to the potential for abuse in
terms of self-dosage at inappropriate levels or frequency.24
Health regulatory authorities have already drawn a
demarcation line between prescribed and non-prescribed
drugs, but this line has been blurred in regard to commu-
nity pharmacies.1 Cooper25 recommended carrying out
community-based research to inform policy, regulation and
the preparedness of healthcare professionals and to avoid
harming those who purchase over-the-counter medicines
that are likely to be abused.25
In KSA, various research studies have pinpointed the
malpractices and violations of pharmaceutical laws in com-
munity pharmacies.26 Furthermore, other researchers27 have
highlighted the need for revisions to regulatory laws,
penalties for those who violate pharmaceutical laws and
structured educational campaigns and training for Saudi
pharmacists. These researchers have further advocated for
the creation, implementation and monitoring of over-the-
counter (OTC) drug lists by Saudi regulators to ensure the
safe and proper dispensing of medicines at retail pharma-
cies.27 Similarly, researchers28 have proposed implementing
pharmaceutical laws through a basic clinical assessment of
community pharmacists and by requiring pharmacists to
undergo educational activities before renewing their
licenses in KSA.28 In addition, Bawazir2 recommended that
pharmacists dispense all prescription-only medicines,
except those drugs defined as OTC. A study conducted in the
eastern province of KSA highlighted the potential for drug
misuse due to the lack of adherence to the regulations gov-
erning the dispensing of drugs by community pharmacies.26
Similar to the aforementioned studies, the present study
also reported on the non-prescription sale of sexual prod-
ucts in Alahsa, which likely mirrors practices in other cities in
KSA. The sale of non-prescription drugs, as well as the
shortcomings of and malpractices in, community pharmacies
in KSA, has been the source of an ongoing debate for the last
two decades; however, no improvements have been noticed
to date. Unfortunately, the results of this study are consistent
with the findings of earlier studies that have noted legal and
professional insufficiencies among community pharmacists
for the past two decades. Structured educational campaigns
for community pharmacists are lacking in KSA; stakeholder
focus on this area may help to ensure the safe and effective
use of drugs.4e6
Studies in Canada29 have emphasized the need for
integrated basic and clinical sciences for women and men’s
health modules, including classroom lectures, large- and
small-group case discussions, self-directed learning assign-
ments and case-based simulations with standardized patients
to address all of the issues related to the sexual health of men
and women.29 In developing countries, though, community
pharmacists lack the necessary professional skills for
dispensing sexual products. This shortcoming may increase
the misuse of these products in patients with other medical
conditions.5Conclusion
In conclusion, the non-prescription dispensing of
prescription-only medicines, including sexual enhancement
Aphrodisiac products without prescriptions 417products, has become very common in KSA. Such
malpractice may result in hazardous consequences for pa-
tient health and for the healthcare system overall. The ma-
jority of pharmacists are violating pharmaceutical laws
without recognizing the potential harm they are imposing
upon their communities. The significant number of expatri-
ates practicing in Saudi community pharmacies could
explain this behaviour. Stakeholders should organize
training and certification programs to ensure that pharma-
cists are aware of and comply with national pharmaceutical
laws and that pharmacies maintain safe and ethical practices.
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